JLK,Inc. (KOSDAQ:322510)

Market Cap	220.39B
Revenue (ttm)	1.63B
Net Income (ttm)	-12.33B
Shares Out	25.13M
EPS (ttm)	-648.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	298,612
Average Volume	459,062
Open	8,440.00
Previous Close	8,440.00
Day's Range	8,400.00 - 8,830.00
52-Week Range	6,340.00 - 16,475.00
Beta	1.43
RSI	51.28
Earnings Date	Mar 17, 2025

About JLK,Inc.

JLK, Inc. provides diagnosis support to the patients with it AI-driven solutions in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides the on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, coro...

• Industry: Prepackaged Software
• CEO: Dongmin Kim
• Employees: 72
• Stock Exchange: KOSDAQ
• Ticker Symbol: 322510

Financial Performance

In 2023, JLK,Inc.'s revenue was 2.49 billion, a decrease of -27.12% compared to the previous year's 3.42 billion. Losses were -7.32 billion, -18.74% less than in 2022.